SME bool | active float64 | activityType string | city string | contactForm string | contentUpdateDate_x string | country string | ecContribution float64 | endOfParticipation bool | geolocation string | name string | netEcContribution float64 | nutsCode string | order int64 | organisationID int64 | organizationURL string | postCode string | projectAcronym string | projectID int64 | rcn_x int64 | role string | shortName string | street string | totalCost_x float64 | vatNumber string | iso3c string | year int64 | countrycode_2 string | cultdist float64 | cultdist_std float64 | n_questions int64 | Unnamed: 0 int64 | ccode int64 | session int64 | NVotesAll int64 | IdealPointAll float64 | QO%All float64 | Q5%All float64 | Q10%All float64 | Q50%All float64 | Q90%All float64 | Q95%All float64 | Q100%All float64 | Countryname string | USAgree float64 | RUSSAgree float64 | BrazilAgree float64 | ChinaAgree float64 | IndiaAgree float64 | IsraelAgree float64 | acronym string | contentUpdateDate_y string | ecMaxContribution float64 | ecSignatureDate string | endDate string | frameworkProgramme string | fundingScheme string | grantDoi string | id int64 | legalBasis string | masterCall string | nature float64 | objective string | rcn_y int64 | startDate string | status string | subCall string | title string | topics string | totalCost_y float64 | topic string | final_domain string | final_method string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
false | null | HES | Leiden | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999974553/101046973 | 2022-07-28 18:48:44 | NL | 535,782.5 | false | 52.1566349,4.4867397 | UNIVERSITEIT LEIDEN | 535,782.5 | NL363 | 2 | 999,974,553 | http://www.universiteitleiden.nl | 2311 EZ | QuCoM | 101,046,973 | 1,906,927 | participant | ULEI | RAPENBURG 70 | 535,782.5 | NL001935549B01 | NLD | 2,021 | ALB | 0.347469 | 0.456996 | 304 | 2,556 | 210 | 78 | 84 | 1.167927 | 0.805154 | 0.974192 | 1.019441 | 1.164798 | 1.318903 | 1.367109 | 1.536957 | Netherlands | 0.578313 | 0.337349 | 0.512195 | 0.426829 | 0.45122 | 0.506173 | QuCoM | 2022-07-28 18:48:44 | 2,270,149.94 | 2022-03-04 | 2025-09-30 | HORIZON | HORIZON-EIC | 10.3030/101046973 | 101,046,973 | HORIZON.3.1 | HORIZON-EIC-2021-PATHFINDEROPEN-01 | null | The main objective of QuCoM is to demonstrate the proof of concept (TRL 1) of a levitated acceleration sensor and its ability detecting gravity of small masses and in the quantum controlled regime. Toward this objective we will explore the interplay between quantum mechanics and gravity in a parameter range accessible ... | 238,520 | 2022-10-01 | SIGNED | HORIZON-EIC-2021-PATHFINDEROPEN-01 | Quantum Control of Gravity with Levitated Mechanics | HORIZON-EIC-2021-PATHFINDEROPEN-01-01 | 2,270,149.94 | F | Fundamental Physics | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Trieste | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999842051/101046973 | 2022-07-28 18:48:44 | IT | 478,388.69 | false | 45.658659,13.7933667 | UNIVERSITA DEGLI STUDI DI TRIESTE | 478,388.69 | ITH44 | 1 | 999,842,051 | http://www.units.it | 34127 | QuCoM | 101,046,973 | 1,906,689 | coordinator | UNITS | PIAZZALE EUROPA 1 | 478,388.69 | IT00211830328 | ITA | 2,021 | ALB | 0.330406 | -0.270665 | 308 | 3,495 | 325 | 78 | 87 | 1.282293 | 0.880163 | 1.081669 | 1.122172 | 1.281629 | 1.44939 | 1.49464 | 1.688013 | Italy | 0.593023 | 0.348837 | 0.476191 | 0.376471 | 0.423529 | 0.511905 | QuCoM | 2022-07-28 18:48:44 | 2,270,149.94 | 2022-03-04 | 2025-09-30 | HORIZON | HORIZON-EIC | 10.3030/101046973 | 101,046,973 | HORIZON.3.1 | HORIZON-EIC-2021-PATHFINDEROPEN-01 | null | The main objective of QuCoM is to demonstrate the proof of concept (TRL 1) of a levitated acceleration sensor and its ability detecting gravity of small masses and in the quantum controlled regime. Toward this objective we will explore the interplay between quantum mechanics and gravity in a parameter range accessible ... | 238,520 | 2022-10-01 | SIGNED | HORIZON-EIC-2021-PATHFINDEROPEN-01 | Quantum Control of Gravity with Levitated Mechanics | HORIZON-EIC-2021-PATHFINDEROPEN-01-01 | 2,270,149.94 | F | Fundamental Physics | Sensor, Monitoring & Measurement Technologies |
true | null | PRC | Leiden | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/913742717/101046973 | 2022-07-28 18:48:44 | NL | 425,215 | false | 52.1561847,4.4446854 | LEIDEN SPIN IMAGING BV | 425,215 | NL363 | 4 | 913,742,717 | null | 2331 BA | QuCoM | 101,046,973 | 1,974,615 | participant | null | KENAUWEG 21 | 425,215 | NL852004436B01 | NLD | 2,021 | ALB | 0.347469 | 0.456996 | 304 | 2,556 | 210 | 78 | 84 | 1.167927 | 0.805154 | 0.974192 | 1.019441 | 1.164798 | 1.318903 | 1.367109 | 1.536957 | Netherlands | 0.578313 | 0.337349 | 0.512195 | 0.426829 | 0.45122 | 0.506173 | QuCoM | 2022-07-28 18:48:44 | 2,270,149.94 | 2022-03-04 | 2025-09-30 | HORIZON | HORIZON-EIC | 10.3030/101046973 | 101,046,973 | HORIZON.3.1 | HORIZON-EIC-2021-PATHFINDEROPEN-01 | null | The main objective of QuCoM is to demonstrate the proof of concept (TRL 1) of a levitated acceleration sensor and its ability detecting gravity of small masses and in the quantum controlled regime. Toward this objective we will explore the interplay between quantum mechanics and gravity in a parameter range accessible ... | 238,520 | 2022-10-01 | SIGNED | HORIZON-EIC-2021-PATHFINDEROPEN-01 | Quantum Control of Gravity with Levitated Mechanics | HORIZON-EIC-2021-PATHFINDEROPEN-01-01 | 2,270,149.94 | F | Fundamental Physics | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Belfast | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999992013/101046973 | 2022-07-28 18:48:44 | UK | null | false | 54.5969869,-5.9300991 | THE QUEEN'S UNIVERSITY OF BELFAST | 0 | UKN06 | 6 | 999,992,013 | http://www.qub.ac.uk | BT7 1NN | QuCoM | 101,046,973 | 1,906,929 | associatedPartner | THE QUEEN'S UNIVERSITY OF BELFAST | UNIVERSITY ROAD LANYON BUILDING | 0 | GB254799511 | GBR | 2,021 | ALB | 0.342713 | 0.255935 | 302 | 2,412 | 200 | 78 | 86 | 2.057023 | 1.583984 | 1.83624 | 1.87805 | 2.05753 | 2.237283 | 2.288665 | 2.522697 | United Kingdom | 0.717647 | 0.341177 | 0.428571 | 0.333333 | 0.380952 | 0.638554 | QuCoM | 2022-07-28 18:48:44 | 2,270,149.94 | 2022-03-04 | 2025-09-30 | HORIZON | HORIZON-EIC | 10.3030/101046973 | 101,046,973 | HORIZON.3.1 | HORIZON-EIC-2021-PATHFINDEROPEN-01 | null | The main objective of QuCoM is to demonstrate the proof of concept (TRL 1) of a levitated acceleration sensor and its ability detecting gravity of small masses and in the quantum controlled regime. Toward this objective we will explore the interplay between quantum mechanics and gravity in a parameter range accessible ... | 238,520 | 2022-10-01 | SIGNED | HORIZON-EIC-2021-PATHFINDEROPEN-01 | Quantum Control of Gravity with Levitated Mechanics | HORIZON-EIC-2021-PATHFINDEROPEN-01-01 | 2,270,149.94 | F | Fundamental Physics | Sensor, Monitoring & Measurement Technologies |
true | null | PRC | Leiden | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/968692247/101046973 | 2022-07-28 18:48:44 | NL | 331,401.25 | false | 52.1614132,4.483506 | LEIDEN CRYOGENICS BV | 331,401.25 | NL363 | 3 | 968,692,247 | https://www.leidencryogenics.com | 2311 VZ | QuCoM | 101,046,973 | 1,940,420 | participant | LC | GALGEWATER 21 | 331,401.25 | NL820838445B01 | NLD | 2,021 | ALB | 0.347469 | 0.456996 | 304 | 2,556 | 210 | 78 | 84 | 1.167927 | 0.805154 | 0.974192 | 1.019441 | 1.164798 | 1.318903 | 1.367109 | 1.536957 | Netherlands | 0.578313 | 0.337349 | 0.512195 | 0.426829 | 0.45122 | 0.506173 | QuCoM | 2022-07-28 18:48:44 | 2,270,149.94 | 2022-03-04 | 2025-09-30 | HORIZON | HORIZON-EIC | 10.3030/101046973 | 101,046,973 | HORIZON.3.1 | HORIZON-EIC-2021-PATHFINDEROPEN-01 | null | The main objective of QuCoM is to demonstrate the proof of concept (TRL 1) of a levitated acceleration sensor and its ability detecting gravity of small masses and in the quantum controlled regime. Toward this objective we will explore the interplay between quantum mechanics and gravity in a parameter range accessible ... | 238,520 | 2022-10-01 | SIGNED | HORIZON-EIC-2021-PATHFINDEROPEN-01 | Quantum Control of Gravity with Levitated Mechanics | HORIZON-EIC-2021-PATHFINDEROPEN-01-01 | 2,270,149.94 | F | Fundamental Physics | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Southampton | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999975329/101046973 | 2022-07-28 18:48:44 | UK | null | false | 50.92996995,-1.39643013613604 | UNIVERSITY OF SOUTHAMPTON | 0 | UKJ32 | 7 | 999,975,329 | http://www.southampton.ac.uk | SO17 1BJ | QuCoM | 101,046,973 | 1,905,627 | associatedPartner | SOUTHAMPTON | Highfield | 0 | GB568630414 | GBR | 2,021 | ALB | 0.342713 | 0.255935 | 302 | 2,412 | 200 | 78 | 86 | 2.057023 | 1.583984 | 1.83624 | 1.87805 | 2.05753 | 2.237283 | 2.288665 | 2.522697 | United Kingdom | 0.717647 | 0.341177 | 0.428571 | 0.333333 | 0.380952 | 0.638554 | QuCoM | 2022-07-28 18:48:44 | 2,270,149.94 | 2022-03-04 | 2025-09-30 | HORIZON | HORIZON-EIC | 10.3030/101046973 | 101,046,973 | HORIZON.3.1 | HORIZON-EIC-2021-PATHFINDEROPEN-01 | null | The main objective of QuCoM is to demonstrate the proof of concept (TRL 1) of a levitated acceleration sensor and its ability detecting gravity of small masses and in the quantum controlled regime. Toward this objective we will explore the interplay between quantum mechanics and gravity in a parameter range accessible ... | 238,520 | 2022-10-01 | SIGNED | HORIZON-EIC-2021-PATHFINDEROPEN-01 | Quantum Control of Gravity with Levitated Mechanics | HORIZON-EIC-2021-PATHFINDEROPEN-01-01 | 2,270,149.94 | F | Fundamental Physics | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Tuebingen | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999991916/101046973 | 2022-07-28 18:48:44 | DE | 499,362.5 | false | 48.52441205,9.05972173269931 | EBERHARD KARLS UNIVERSITAET TUEBINGEN | 499,362.5 | DE142 | 5 | 999,991,916 | http://www.uni-tuebingen.de | 72074 | QuCoM | 101,046,973 | 1,905,979 | participant | UT | GESCHWISTER-SCHOLL-PLATZ | 499,362.5 | DE812383453 | DEU | 2,021 | ALB | 0.333761 | -0.126194 | 313 | 3,073 | 255 | 78 | 87 | 1.33508 | 0.982728 | 1.13156 | 1.174173 | 1.331788 | 1.501628 | 1.542218 | 1.770471 | Germany | 0.593023 | 0.337209 | 0.476191 | 0.388235 | 0.411765 | 0.511905 | QuCoM | 2022-07-28 18:48:44 | 2,270,149.94 | 2022-03-04 | 2025-09-30 | HORIZON | HORIZON-EIC | 10.3030/101046973 | 101,046,973 | HORIZON.3.1 | HORIZON-EIC-2021-PATHFINDEROPEN-01 | null | The main objective of QuCoM is to demonstrate the proof of concept (TRL 1) of a levitated acceleration sensor and its ability detecting gravity of small masses and in the quantum controlled regime. Toward this objective we will explore the interplay between quantum mechanics and gravity in a parameter range accessible ... | 238,520 | 2022-10-01 | SIGNED | HORIZON-EIC-2021-PATHFINDEROPEN-01 | Quantum Control of Gravity with Levitated Mechanics | HORIZON-EIC-2021-PATHFINDEROPEN-01-01 | 2,270,149.94 | F | Fundamental Physics | Sensor, Monitoring & Measurement Technologies |
true | null | PRC | ORPINGTON | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/883371241/101130618 | 2024-03-18 18:33:43 | UK | null | false | 51.3805351,0.1062656 | NEUROLANE LTD | 0 | UKI61 | 9 | 883,371,241 | null | BR5 4EU | SWEATPATCH | 101,130,618 | 1,987,295 | associatedPartner | null | WALDEN MANOR, WALDENS ROAD ORPINGTON, KENT | 0 | GB453643194 | GBR | 2,021 | ALB | 0.342713 | 0.255935 | 302 | 2,412 | 200 | 78 | 86 | 2.057023 | 1.583984 | 1.83624 | 1.87805 | 2.05753 | 2.237283 | 2.288665 | 2.522697 | United Kingdom | 0.717647 | 0.341177 | 0.428571 | 0.333333 | 0.380952 | 0.638554 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | REC | San Giovanni Rotondo Fg | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/998461450/101130618 | 2024-03-18 18:33:43 | IT | 201,345 | false | 41.7050554,15.7306463 | FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA | 201,345 | ITF46 | 5 | 998,461,450 | http://www.operapadrepio.it | 71013 | SWEATPATCH | 101,130,618 | 1,962,740 | participant | CSS -IRCCS | VIALE CAPPUCCINI SC | 301,345 | IT00138660717 | ITA | 2,021 | ALB | 0.330406 | -0.270665 | 308 | 3,495 | 325 | 78 | 87 | 1.282293 | 0.880163 | 1.081669 | 1.122172 | 1.281629 | 1.44939 | 1.49464 | 1.688013 | Italy | 0.593023 | 0.348837 | 0.476191 | 0.376471 | 0.423529 | 0.511905 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Villeneuve D Ascq Cedex | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999878038/101130618 | 2024-03-18 18:33:43 | FR | 595,182.5 | false | 50.60651015,3.13758080168219 | CENTRALE LILLE INSTITUT | 595,182.5 | FRE11 | 1 | 999,878,038 | http://www.ec-lille.fr | 59651 | SWEATPATCH | 101,130,618 | 1,906,590 | coordinator | null | CITE SCIENTIFIQUE, BOULEVARD PAUL LANGEVIN | 595,182.5 | FR16195903497 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | OTH | Lille | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/992641935/101130618 | 2024-03-18 18:33:43 | FR | 0 | false | 50.6140995,3.0379645 | CENTRE OSCAR LAMBRET | 100,000 | FRE11 | 6 | 992,641,935 | null | 59020 | SWEATPATCH | 101,130,618 | 2,720,041 | thirdParty | null | RUE FREDERIC COMBEMALE 3 | 0 | FR33783697345 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
true | null | PRC | Kranj | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/929039035/101130618 | 2024-03-18 18:33:43 | SI | 291,250 | false | 46.24549,14.3637553 | CARETRONIC RAZVOJ IN PROIZVODNJA NAPREDNIH INFORMACIJSKIH RESITEV D.O.O. | 291,250 | SI042 | 7 | 929,039,035 | null | 4000 | SWEATPATCH | 101,130,618 | 1,973,266 | participant | null | STIRNOVA ULICA 8 | 291,250 | SI34280057 | SVN | 2,021 | ALB | 0.321868 | -0.641847 | 312 | 3,867 | 349 | 78 | 87 | 1.083891 | 0.748178 | 0.895975 | 0.936269 | 1.08076 | 1.233182 | 1.266966 | 1.450852 | Slovenia | 0.569767 | 0.383721 | 0.535714 | 0.447059 | 0.423529 | 0.488095 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Bordeaux | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/949735440/101130618 | 2024-03-18 18:33:43 | FR | 388,931.25 | false | 44.8371333,-0.5780207 | UNIVERSITE DE BORDEAUX | 343,001.25 | FRI12 | 3 | 949,735,440 | http://www.nouvelle-univ-bordeaux.fr | 33000 | SWEATPATCH | 101,130,618 | 1,908,313 | participant | UBx | PLACE PEY BERLAND 35 | 424,361.25 | FR23130018351 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Talence | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/991798035/101130618 | 2024-03-18 18:33:43 | FR | 0 | false | 44.8088438,-0.5879629 | INSTITUT POLYTECHNIQUE DE BORDEAUX | 45,930 | FRI12 | 3 | 991,798,035 | null | 33402 | SWEATPATCH | 101,130,618 | 2,118,471 | thirdParty | Bordeaux INP | AV DU DOCTEUR ALBERT SCHWEITZER 1 | 0 | FR25130006356 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | REC | Meldola | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/998400534/101130618 | 2024-03-18 18:33:43 | IT | 238,983.75 | false | 44.1252926,12.0632802 | ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI DINO AMADORI - IRST SRL | 238,983.75 | ITH58 | 4 | 998,400,534 | null | 47014 | SWEATPATCH | 101,130,618 | 3,146,258 | participant | IRST | VIA MARONCELLI 40 | 238,983.75 | IT03154520401 | ITA | 2,021 | ALB | 0.330406 | -0.270665 | 308 | 3,495 | 325 | 78 | 87 | 1.282293 | 0.880163 | 1.081669 | 1.122172 | 1.281629 | 1.44939 | 1.49464 | 1.688013 | Italy | 0.593023 | 0.348837 | 0.476191 | 0.376471 | 0.423529 | 0.511905 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | PRC | Milano | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/883190336/101130618 | 2024-03-18 18:33:43 | IT | 191,250 | false | 45.4633043,9.1823857 | INVENSENSE ITALY S.R.L. | 191,250 | ITC4C | 8 | 883,190,336 | null | 20123 | SWEATPATCH | 101,130,618 | 1,987,296 | participant | null | PIAZZA BORROMEO 14 | 191,250 | IT08794480965 | ITA | 2,021 | ALB | 0.330406 | -0.270665 | 308 | 3,495 | 325 | 78 | 87 | 1.282293 | 0.880163 | 1.081669 | 1.122172 | 1.281629 | 1.44939 | 1.49464 | 1.688013 | Italy | 0.593023 | 0.348837 | 0.476191 | 0.376471 | 0.423529 | 0.511905 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Lille | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/888146648/101130618 | 2024-03-18 18:33:43 | FR | 407,741.25 | false | 50.6323392,3.0752353 | UNIVERSITE DE LILLE | 307,741.25 | FRE11 | 6 | 888,146,648 | null | 59000 | SWEATPATCH | 101,130,618 | 1,973,617 | participant | UNIVERSITE DE LILLE | 42 RUE PAUL DUEZ | 407,741.25 | FR88130029754 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Valencia | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999864846/101130618 | 2024-03-18 18:33:43 | ES | 356,250 | false | 39.48106345342516,-0.341087800922881 | UNIVERSITAT POLITECNICA DE VALENCIA | 356,250 | ES523 | 2 | 999,864,846 | http://www.upv.es | 46022 | SWEATPATCH | 101,130,618 | 1,905,898 | participant | UPV | CAMINO DE VERA SN EDIFICIO 3A | 356,250 | ESQ4618002B | ESP | 2,021 | ALB | 0.328814 | -0.339501 | 316 | 2,942 | 230 | 78 | 87 | 1.129384 | 0.678131 | 0.949979 | 0.98888 | 1.130769 | 1.272382 | 1.314985 | 1.541375 | Spain | 0.604651 | 0.395349 | 0.52381 | 0.423529 | 0.423529 | 0.511905 | SWEATPATCH | 2024-03-18 18:33:43 | 2,670,933.75 | 2024-03-12 | 2028-03-31 | HORIZON | HORIZON-EIC | 10.3030/101130618 | 101,130,618 | HORIZON.3.1 | HORIZON-EIC-2023-PATHFINDEROPEN-01 | null | Breast Cancer (BC) is the most common cancer in Europe. In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs. However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time. There... | 260,610 | 2024-04-01 | SIGNED | HORIZON-EIC-2023-PATHFINDEROPEN-01 | Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response | HORIZON-EIC-2023-PATHFINDEROPEN-01-01 | 2,806,363.75 | U | Clinical Medicine & Health Sciences | Sensor, Monitoring & Measurement Technologies |
false | null | HES | Cambridge | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999977172/101137157 | 2024-01-08 20:29:05 | UK | null | false | 52.20533055,0.1169200339484217 | THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE | 0 | UKH12 | 6 | 999,977,172 | http://www.cam.ac.uk | CB2 1TN | e-FabRIC | 101,137,157 | 1,905,558 | associatedPartner | null | TRINITY LANE THE OLD SCHOOLS | 0 | GB823847609 | GBR | 2,021 | ALB | 0.342713 | 0.255935 | 302 | 2,412 | 200 | 78 | 86 | 2.057023 | 1.583984 | 1.83624 | 1.87805 | 2.05753 | 2.237283 | 2.288665 | 2.522697 | United Kingdom | 0.717647 | 0.341177 | 0.428571 | 0.333333 | 0.380952 | 0.638554 | e-FabRIC | 2024-01-08 20:29:05 | 7,666,548.75 | 2023-12-07 | 2027-11-30 | HORIZON | HORIZON-RIA | 10.3030/101137157 | 101,137,157 | HORIZON.2.1 | HORIZON-HLTH-2023-DISEASE-03 | null | e-FabRIC will develop a new hyperimmunization strategy for generating high titers equine immunoglobulins having a broad neutralizing specificity against viral targets belonging to same subfamily phylogenic tree. The viral subfamily selected to demonstrate the unique benefits of this innovative way to induce highly anti... | 259,002 | 2023-12-01 | SIGNED | HORIZON-HLTH-2023-DISEASE-03 | enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy against Coronaviruses | HORIZON-HLTH-2023-DISEASE-03-04 | 7,666,548.75 | M | Drug Discovery & Pharmaceutical Sciences | Bioprocessing & Biomanufacturing Techniques |
false | null | OTH | Madrid | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/998528962/101137157 | 2024-01-08 20:29:05 | ES | 496,625 | false | 40.4573216,-3.5618523593554 | FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO 12 DE OCTUBRE | 496,625 | ES300 | 3 | 998,528,962 | http://www.h12o.es | 28041 | e-FabRIC | 101,137,157 | 2,118,420 | participant | FIB-H12O | AVENIDA DE CORDOBA SN | 496,625 | ESG83727016 | ESP | 2,021 | ALB | 0.328814 | -0.339501 | 316 | 2,942 | 230 | 78 | 87 | 1.129384 | 0.678131 | 0.949979 | 0.98888 | 1.130769 | 1.272382 | 1.314985 | 1.541375 | Spain | 0.604651 | 0.395349 | 0.52381 | 0.423529 | 0.423529 | 0.511905 | e-FabRIC | 2024-01-08 20:29:05 | 7,666,548.75 | 2023-12-07 | 2027-11-30 | HORIZON | HORIZON-RIA | 10.3030/101137157 | 101,137,157 | HORIZON.2.1 | HORIZON-HLTH-2023-DISEASE-03 | null | e-FabRIC will develop a new hyperimmunization strategy for generating high titers equine immunoglobulins having a broad neutralizing specificity against viral targets belonging to same subfamily phylogenic tree. The viral subfamily selected to demonstrate the unique benefits of this innovative way to induce highly anti... | 259,002 | 2023-12-01 | SIGNED | HORIZON-HLTH-2023-DISEASE-03 | enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy against Coronaviruses | HORIZON-HLTH-2023-DISEASE-03-04 | 7,666,548.75 | M | Drug Discovery & Pharmaceutical Sciences | Bioprocessing & Biomanufacturing Techniques |
true | null | PRC | Lyon | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/935451220/101137157 | 2024-01-08 20:29:05 | FR | 4,413,588.75 | false | 45.7710735,4.8215953 | FABENTECH | 4,413,588.75 | FRK26 | 1 | 935,451,220 | null | 69007 | e-FabRIC | 101,137,157 | 2,542,702 | coordinator | FABENTECH | 24 RUE JEAN BALDASSINI IMMEUBLE TONY GARNIER | 4,413,588.75 | FR33512823972 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | e-FabRIC | 2024-01-08 20:29:05 | 7,666,548.75 | 2023-12-07 | 2027-11-30 | HORIZON | HORIZON-RIA | 10.3030/101137157 | 101,137,157 | HORIZON.2.1 | HORIZON-HLTH-2023-DISEASE-03 | null | e-FabRIC will develop a new hyperimmunization strategy for generating high titers equine immunoglobulins having a broad neutralizing specificity against viral targets belonging to same subfamily phylogenic tree. The viral subfamily selected to demonstrate the unique benefits of this innovative way to induce highly anti... | 259,002 | 2023-12-01 | SIGNED | HORIZON-HLTH-2023-DISEASE-03 | enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy against Coronaviruses | HORIZON-HLTH-2023-DISEASE-03-04 | 7,666,548.75 | M | Drug Discovery & Pharmaceutical Sciences | Bioprocessing & Biomanufacturing Techniques |
true | null | PRC | Apprieu | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/951337201/101137157 | 2024-01-08 20:29:05 | FR | 444,125 | false | 45.3898674,5.4756485 | SOCIETE DES SYSTEMES BIOLOGIQUES SARL | 444,125 | FRK24 | 4 | 951,337,201 | http://www.biotem.fr | 38140 | e-FabRIC | 101,137,157 | 2,002,360 | participant | BIOTEM | RUE ALPHONSE GORJU 885 | 444,125 | FR13320508047 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | e-FabRIC | 2024-01-08 20:29:05 | 7,666,548.75 | 2023-12-07 | 2027-11-30 | HORIZON | HORIZON-RIA | 10.3030/101137157 | 101,137,157 | HORIZON.2.1 | HORIZON-HLTH-2023-DISEASE-03 | null | e-FabRIC will develop a new hyperimmunization strategy for generating high titers equine immunoglobulins having a broad neutralizing specificity against viral targets belonging to same subfamily phylogenic tree. The viral subfamily selected to demonstrate the unique benefits of this innovative way to induce highly anti... | 259,002 | 2023-12-01 | SIGNED | HORIZON-HLTH-2023-DISEASE-03 | enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy against Coronaviruses | HORIZON-HLTH-2023-DISEASE-03-04 | 7,666,548.75 | M | Drug Discovery & Pharmaceutical Sciences | Bioprocessing & Biomanufacturing Techniques |
false | null | PRC | Bruxelles / Brussel | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/886071333/101137157 | 2024-01-08 20:29:05 | BE | 516,437.5 | false | 50.8419155,4.3852222 | FIPRA INTERNATIONAL SRL | 516,437.5 | BE100 | 5 | 886,071,333 | null | 1040 | e-FabRIC | 101,137,157 | 1,978,645 | participant | null | 227 RUE DE LA LOI | 516,437.5 | BE0733774811 | BEL | 2,021 | ALB | 0.341727 | 0.214094 | 260 | 2,633 | 211 | 78 | 87 | 1.128491 | 0.774714 | 0.929021 | 0.97841 | 1.126574 | 1.279498 | 1.31974 | 1.533236 | Belgium | 0.593023 | 0.395349 | 0.535714 | 0.435294 | 0.458824 | 0.511905 | e-FabRIC | 2024-01-08 20:29:05 | 7,666,548.75 | 2023-12-07 | 2027-11-30 | HORIZON | HORIZON-RIA | 10.3030/101137157 | 101,137,157 | HORIZON.2.1 | HORIZON-HLTH-2023-DISEASE-03 | null | e-FabRIC will develop a new hyperimmunization strategy for generating high titers equine immunoglobulins having a broad neutralizing specificity against viral targets belonging to same subfamily phylogenic tree. The viral subfamily selected to demonstrate the unique benefits of this innovative way to induce highly anti... | 259,002 | 2023-12-01 | SIGNED | HORIZON-HLTH-2023-DISEASE-03 | enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy against Coronaviruses | HORIZON-HLTH-2023-DISEASE-03-04 | 7,666,548.75 | M | Drug Discovery & Pharmaceutical Sciences | Bioprocessing & Biomanufacturing Techniques |
false | null | HES | ANTWERPEN | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999883276/101137157 | 2024-01-08 20:29:05 | BE | 1,795,772.5 | false | 51.212314649999996,4.3983476766030005 | INSTITUUT VOOR TROPISCHE GENEESKUNDE | 1,795,772.5 | BE211 | 2 | 999,883,276 | http://www.itg.be | 2000 | e-FabRIC | 101,137,157 | 1,906,316 | participant | ITM | NATIONALESTRAAT 155 | 1,795,772.5 | BE0410057701 | BEL | 2,021 | ALB | 0.341727 | 0.214094 | 260 | 2,633 | 211 | 78 | 87 | 1.128491 | 0.774714 | 0.929021 | 0.97841 | 1.126574 | 1.279498 | 1.31974 | 1.533236 | Belgium | 0.593023 | 0.395349 | 0.535714 | 0.435294 | 0.458824 | 0.511905 | e-FabRIC | 2024-01-08 20:29:05 | 7,666,548.75 | 2023-12-07 | 2027-11-30 | HORIZON | HORIZON-RIA | 10.3030/101137157 | 101,137,157 | HORIZON.2.1 | HORIZON-HLTH-2023-DISEASE-03 | null | e-FabRIC will develop a new hyperimmunization strategy for generating high titers equine immunoglobulins having a broad neutralizing specificity against viral targets belonging to same subfamily phylogenic tree. The viral subfamily selected to demonstrate the unique benefits of this innovative way to induce highly anti... | 259,002 | 2023-12-01 | SIGNED | HORIZON-HLTH-2023-DISEASE-03 | enhanced manufacturing of broadly potent equine polyclonal Fab with a Rational Immunization strategy against Coronaviruses | HORIZON-HLTH-2023-DISEASE-03-04 | 7,666,548.75 | M | Drug Discovery & Pharmaceutical Sciences | Bioprocessing & Biomanufacturing Techniques |
true | null | PRC | Lund | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/905399553/190127219 | 2024-12-05 16:26:04 | SE | 2,230,783.63 | false | 59.6749712,14.5208584 | HEXAGEM AB | 2,230,783.63 | SE224 | 1 | 905,399,553 | null | 223 63 | InGaNious | 190,127,219 | 1,956,071 | coordinator | Hexagem | IDEON ALFA 3 SCHEELEVAGEN 15 | 3,186,833.75 | SE559039446501 | SWE | 2,021 | ALB | 0.349485 | 0.541802 | 320 | 4,745 | 380 | 78 | 87 | 1.224445 | 0.867613 | 1.028701 | 1.068138 | 1.222568 | 1.37962 | 1.42632 | 1.669371 | Sweden | 0.581395 | 0.360465 | 0.5 | 0.411765 | 0.411765 | 0.5 | InGaNious | 2024-12-05 16:26:04 | 2,230,783.63 | 2022-12-13 | 2025-06-30 | HORIZON | HORIZON-EIC-ACC-BF | 10.3030/190127219 | 190,127,219 | HORIZON.3.1 | HORIZON-EIC-2022-ACCELERATOR-01 | null | Our method of growing pure InGaN LEDs is completely unique. We start with a layer of thin GaN on a substrate. This layer has the same high defect density that other existing technologies struggle with. Then we add a mask made of either silicon nitride or aluminum oxide introduced by us using a high-resolution lithograp... | 243,957 | 2023-02-01 | SIGNED | HORIZON-EIC-2022-ACCELERATOR-01 | Next-Generation Indium Gallium Nitride Micro LEDs | HORIZON-EIC-2022-ACCELERATOROPEN-01 | 3,186,833.75 | Z | Photonics, Optoelectronics & Microelectronics | Engineering Design, Fabrication & Process Methods |
false | null | REC | Wien | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999584128/101187539 | 2024-11-08 14:34:28 | AT | 985,393 | false | 48.2690574,16.427193727293183 | AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH | 985,393 | AT130 | 1 | 999,584,128 | http://www.ait.ac.at/ | 1210 | QOSiLICIOUS | 101,187,539 | 1,905,899 | coordinator | AIT | GIEFINGGASSE 4 | 985,393 | ATU14703506 | AUT | 2,021 | ALB | 0.33304 | -0.15716 | 287 | 3,252 | 305 | 78 | 87 | 0.997413 | 0.696646 | 0.83297 | 0.870862 | 1.00098 | 1.125461 | 1.169733 | 1.368155 | Austria | 0.546512 | 0.267442 | 0.583333 | 0.411765 | 0.435294 | 0.488095 | QOSiLICIOUS | 2024-11-08 14:34:28 | 3,481,857.25 | 2024-11-04 | 2029-01-31 | HORIZON | HORIZON-EIC | 10.3030/101187539 | 101,187,539 | HORIZON.3.1 | HORIZON-EIC-2024-PATHFINDEROPEN-01 | null | The rapid rise of quantum computation has raised concerns about conventional encryption methods. In response to this emerging threat, quantum key distribution (QKD) offers an information-theoretically secure key exchange. However, its complexity currently hinders its widespread adoption.
QOSiLICIOUS introduces a disrup... | 267,245 | 2025-02-01 | SIGNED | HORIZON-EIC-2024-PATHFINDEROPEN-01 | Quantum-Optic Silicon as a Commodity: Extending the Trust Continuum till the Edge of ICT Networks | HORIZON-EIC-2024-PATHFINDEROPEN-01-01 | 3,481,857.25 | C | Photonics, Optoelectronics & Microelectronics | Quantum Methods & Technologies |
false | null | REC | Frankfurt Oder | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999606438/101187539 | 2024-11-08 14:34:28 | DE | 852,713 | false | 52.3178385,14.493394084999998 | IHP GMBH - LEIBNIZ INSTITUTE FOR HIGH PERFORMANCE MICROELECTRONICS | 852,713 | DE403 | 2 | 999,606,438 | null | 15236 | QOSiLICIOUS | 101,187,539 | 1,956,973 | participant | LEIBNIZ-INSTITUT FUR INNOVATIVE MIKROELEKTRONIK | IM TECHNOLOGIEPARK 25 | 852,713 | DE138996546 | DEU | 2,021 | ALB | 0.333761 | -0.126194 | 313 | 3,073 | 255 | 78 | 87 | 1.33508 | 0.982728 | 1.13156 | 1.174173 | 1.331788 | 1.501628 | 1.542218 | 1.770471 | Germany | 0.593023 | 0.337209 | 0.476191 | 0.388235 | 0.411765 | 0.511905 | QOSiLICIOUS | 2024-11-08 14:34:28 | 3,481,857.25 | 2024-11-04 | 2029-01-31 | HORIZON | HORIZON-EIC | 10.3030/101187539 | 101,187,539 | HORIZON.3.1 | HORIZON-EIC-2024-PATHFINDEROPEN-01 | null | The rapid rise of quantum computation has raised concerns about conventional encryption methods. In response to this emerging threat, quantum key distribution (QKD) offers an information-theoretically secure key exchange. However, its complexity currently hinders its widespread adoption.
QOSiLICIOUS introduces a disrup... | 267,245 | 2025-02-01 | SIGNED | HORIZON-EIC-2024-PATHFINDEROPEN-01 | Quantum-Optic Silicon as a Commodity: Extending the Trust Continuum till the Edge of ICT Networks | HORIZON-EIC-2024-PATHFINDEROPEN-01-01 | 3,481,857.25 | C | Photonics, Optoelectronics & Microelectronics | Quantum Methods & Technologies |
false | null | PRC | YOKNEAM | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/990560024/101187539 | 2024-11-08 14:34:28 | IL | 675,926.25 | false | 32.667376,35.108328 | MELLANOX TECHNOLOGIES LTD - MLNX | 675,926.25 | IL | 3 | 990,560,024 | https://www.mellanox.com | 20692 | QOSiLICIOUS | 101,187,539 | 2,379,968 | participant | MELLANOX | YOKNEAM ILIT INDUSTRIAL ZONE HERMON BUILDING | 675,926.25 | IL512763285 | ISR | 2,021 | ALB | 0.331459 | -0.225252 | 48 | 8,598 | 666 | 78 | 85 | 2.282461 | 1.885509 | 2.072619 | 2.114899 | 2.278675 | 2.451227 | 2.504132 | 2.687625 | Israel | 0.880952 | 0.190476 | 0.280488 | 0.204819 | 0.253012 | 1 | QOSiLICIOUS | 2024-11-08 14:34:28 | 3,481,857.25 | 2024-11-04 | 2029-01-31 | HORIZON | HORIZON-EIC | 10.3030/101187539 | 101,187,539 | HORIZON.3.1 | HORIZON-EIC-2024-PATHFINDEROPEN-01 | null | The rapid rise of quantum computation has raised concerns about conventional encryption methods. In response to this emerging threat, quantum key distribution (QKD) offers an information-theoretically secure key exchange. However, its complexity currently hinders its widespread adoption.
QOSiLICIOUS introduces a disrup... | 267,245 | 2025-02-01 | SIGNED | HORIZON-EIC-2024-PATHFINDEROPEN-01 | Quantum-Optic Silicon as a Commodity: Extending the Trust Continuum till the Edge of ICT Networks | HORIZON-EIC-2024-PATHFINDEROPEN-01-01 | 3,481,857.25 | C | Photonics, Optoelectronics & Microelectronics | Quantum Methods & Technologies |
false | null | HES | Glasgow | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999974165/101187539 | 2024-11-08 14:34:28 | UK | 967,825 | false | 55.8720216,-4.2854872 | UNIVERSITY OF GLASGOW | 967,825 | UKM82 | 4 | 999,974,165 | http://www.gla.ac.uk/researchinstitutes/iii/staff/iainmcinnes/ | G12 8QQ | QOSiLICIOUS | 101,187,539 | 1,906,499 | participant | null | UNIVERSITY AVENUE | 967,825 | GB671798093 | GBR | 2,021 | ALB | 0.342713 | 0.255935 | 302 | 2,412 | 200 | 78 | 86 | 2.057023 | 1.583984 | 1.83624 | 1.87805 | 2.05753 | 2.237283 | 2.288665 | 2.522697 | United Kingdom | 0.717647 | 0.341177 | 0.428571 | 0.333333 | 0.380952 | 0.638554 | QOSiLICIOUS | 2024-11-08 14:34:28 | 3,481,857.25 | 2024-11-04 | 2029-01-31 | HORIZON | HORIZON-EIC | 10.3030/101187539 | 101,187,539 | HORIZON.3.1 | HORIZON-EIC-2024-PATHFINDEROPEN-01 | null | The rapid rise of quantum computation has raised concerns about conventional encryption methods. In response to this emerging threat, quantum key distribution (QKD) offers an information-theoretically secure key exchange. However, its complexity currently hinders its widespread adoption.
QOSiLICIOUS introduces a disrup... | 267,245 | 2025-02-01 | SIGNED | HORIZON-EIC-2024-PATHFINDEROPEN-01 | Quantum-Optic Silicon as a Commodity: Extending the Trust Continuum till the Edge of ICT Networks | HORIZON-EIC-2024-PATHFINDEROPEN-01-01 | 3,481,857.25 | C | Photonics, Optoelectronics & Microelectronics | Quantum Methods & Technologies |
true | null | PRC | Livorno | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999604789/101159364 | 2024-03-18 18:39:15 | IT | 2,498,750 | false | 43.5271505,10.3153836 | QUANTAVIS SRL | 2,498,750 | ITI16 | 1 | 999,604,789 | null | 57128 | entropIC | 101,159,364 | 2,184,861 | coordinator | QUANTAVIS | VIA DEI PENSIERI 60 | 2,498,750 | IT01553430495 | ITA | 2,021 | ALB | 0.330406 | -0.270665 | 308 | 3,495 | 325 | 78 | 87 | 1.282293 | 0.880163 | 1.081669 | 1.122172 | 1.281629 | 1.44939 | 1.49464 | 1.688013 | Italy | 0.593023 | 0.348837 | 0.476191 | 0.376471 | 0.423529 | 0.511905 | entropIC | 2024-03-18 18:39:15 | 2,498,750 | 2024-03-15 | 2027-06-30 | HORIZON | HORIZON-EIC | 10.3030/101159364 | 101,159,364 | HORIZON.3.1 | HORIZON-EIC-2023-TRANSITION-01 | null | The EntropIC project aims to advance the technology and market maturity of a comprehensive anti-counterfeiting and identity management solution based on proprietary silicon integrated circuits implementing high-entropy physical unclonable functions.
Physical Unclonable Functions (PUFs) are silicon integrated circuits t... | 260,756 | 2024-07-01 | SIGNED | HORIZON-EIC-2023-TRANSITION-01 | Anticounterfeiting solution based on integrated circuits implementing high-entropy physical unclonable functions | HORIZON-EIC-2023-TRANSITIONOPEN-01 | 2,498,750 | I | Photonics, Optoelectronics & Microelectronics | Engineering Design, Fabrication & Process Methods |
true | null | PRC | Nice | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/941100888/190183888 | 2022-10-17 19:10:15 | FR | 1,992,550 | false | 43.6134385,7.0504267 | KLEARIA | 1,992,550 | FRL03 | 1 | 941,100,888 | null | 6200 | PANDa | 190,183,888 | 1,959,388 | coordinator | null | 61 AVENUE SIMONE VEIL | 2,846,500 | FR57789701653 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | PANDa | 2022-10-17 19:10:15 | 1,992,550 | 2022-10-14 | 2025-04-30 | HORIZON | HORIZON-EIC-ACC-BF | 10.3030/190183888 | 190,183,888 | HORIZON.3.1 | HORIZON-EIC-2022-ACCELERATOR-01 | null | Klearia enables real time control for efficient treatment management and good quality water. We develop and produce advanced electrochemical multi-element water analysers based on our patented microfluidics chips LabInGlass. There is a high demand for testing technologies capable of detecting, identifying and quantifyi... | 242,513 | 2022-11-01 | SIGNED | HORIZON-EIC-2022-ACCELERATOR-01 | PANDa - Portable Multi-ANalyzer for the Detection of metals in water | HORIZON-EIC-2022-ACCELERATORCHALLENGES-02 | 2,846,500 | A | Environmental Engineering & Health | Computational Modeling, Simulation & Optimization |
true | null | PRC | Eindhoven | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/889833478/101099230 | 2023-04-05 13:17:14 | NL | 2,307,188 | false | 51.4497136,5.4971925 | PHOTONIP B.V. | 2,307,188 | NL414 | 1 | 889,833,478 | null | 5612AJ | NARWHAL | 101,099,230 | 1,978,994 | coordinator | null | DE ZAALE 11 | 2,307,188 | NL861269378B01 | NLD | 2,021 | ALB | 0.347469 | 0.456996 | 304 | 2,556 | 210 | 78 | 84 | 1.167927 | 0.805154 | 0.974192 | 1.019441 | 1.164798 | 1.318903 | 1.367109 | 1.536957 | Netherlands | 0.578313 | 0.337349 | 0.512195 | 0.426829 | 0.45122 | 0.506173 | NARWHAL | 2023-04-05 13:17:14 | 2,307,188 | 2022-10-26 | 2025-04-30 | HORIZON | HORIZON-EIC | 10.3030/101099230 | 101,099,230 | HORIZON.3.1 | HORIZON-EIC-2022-TRANSITION-01 | null | Quantum computing, forecasted to happen within 10 years, will bring unprecedented computing power, rendering obsolete current data security protocols based on public keys, affecting our open society, our business and basic individual rights. Quantum key distribution (QKD) technology can solve this strategic data securi... | 242,890 | 2022-11-01 | SIGNED | HORIZON-EIC-2022-TRANSITION-01 | A Quantum System on Chip for equal access to secure communications: a pilot-ready photonic integrated circuit with embedded quantum key distribution functions for high-performance transceivers. | HORIZON-EIC-2022-TRANSITIONOPEN-01 | 2,307,188 | A | Information & Communication Technologies | Photonics & Optical Methods |
true | null | PRC | Heverlee | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/922739855/190153654 | 2022-11-09 17:19:45 | BE | 2,482,564 | false | 50.6402809,4.6667145 | XENOMATIX | 2,482,564 | BE242 | 1 | 922,739,855 | null | 3001 | SE€ | 190,153,654 | 3,006,580 | coordinator | XENOMATIX | ROMEINSESTRAAT 6 | 3,546,520 | BE0537868067 | BEL | 2,021 | ALB | 0.341727 | 0.214094 | 260 | 2,633 | 211 | 78 | 87 | 1.128491 | 0.774714 | 0.929021 | 0.97841 | 1.126574 | 1.279498 | 1.31974 | 1.533236 | Belgium | 0.593023 | 0.395349 | 0.535714 | 0.435294 | 0.458824 | 0.511905 | SE€ | 2022-11-09 17:19:45 | 2,482,564 | 2022-10-26 | 2024-10-31 | HORIZON | HORIZON-EIC-ACC-BF | 10.3030/190153654 | 190,153,654 | HORIZON.3.1 | HORIZON-EIC-2022-ACCELERATOR-01 | null | Xenomatix is radically innovating the standard operating principle of LiDAR by introducing a light-based 3D measurement system, and is the first to design the by market defined holy grail being a true solid state LiDAR. XenomatiX’s unique all semiconductor-based design is first to meet cost, size, and robustness requir... | 242,799 | 2022-11-01 | SIGNED | HORIZON-EIC-2022-ACCELERATOR-01 | Unlocking LiDAR technology for European OEMS: For a future of smart and safe Traffic and Mobility | HORIZON-EIC-2022-ACCELERATOROPEN-01 | 3,546,520 | T | Transportation & Urban Systems | Engineering Design, Fabrication & Process Methods |
true | null | PRC | BARCELONA | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/879553903/101181982 | 2024-10-09 16:54:07 | ES | 213,750 | false | 41.3919898,2.165635 | ATOVA REGULATORY CONSULTING | 213,750 | ES511 | 8 | 879,553,903 | null | 8007 | PLANTOMYC | 101,181,982 | 1,989,855 | participant | ATOVA REGULATORY CONSULTING | PASSEIG DE GRACIA 50, 5 | 213,750 | ESB09948431 | ESP | 2,021 | ALB | 0.328814 | -0.339501 | 316 | 2,942 | 230 | 78 | 87 | 1.129384 | 0.678131 | 0.949979 | 0.98888 | 1.130769 | 1.272382 | 1.314985 | 1.541375 | Spain | 0.604651 | 0.395349 | 0.52381 | 0.423529 | 0.423529 | 0.511905 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
false | null | HES | Reading | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999984156/101181982 | 2024-10-09 16:54:07 | UK | 420,153.25 | false | 51.44037525,-0.941692556910192 | THE UNIVERSITY OF READING | 420,153.25 | UKJ11 | 3 | 999,984,156 | http://www.rdg.ac.uk | RG6 6AH | PLANTOMYC | 101,181,982 | 1,905,957 | participant | null | WHITEKNIGHTS CAMPUS WHITEKNIGHTS HOUSE | 420,153.25 | GB200012659 | GBR | 2,021 | ALB | 0.342713 | 0.255935 | 302 | 2,412 | 200 | 78 | 86 | 2.057023 | 1.583984 | 1.83624 | 1.87805 | 2.05753 | 2.237283 | 2.288665 | 2.522697 | United Kingdom | 0.717647 | 0.341177 | 0.428571 | 0.333333 | 0.380952 | 0.638554 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
false | null | REC | AMSTERDAM | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999518362/101181982 | 2024-10-09 16:54:07 | NL | 261,347.5 | false | 52.3745403,4.89797550561798 | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW | 261,347.5 | NL32B | 4 | 999,518,362 | http://www.hubrecht.eu/ | 1011 JV | PLANTOMYC | 101,181,982 | 1,905,735 | participant | KNAW | KLOVENIERSBURGWAL 29 HET TRIPPENHUIS | 261,347.5 | NL002958697B01 | NLD | 2,021 | ALB | 0.347469 | 0.456996 | 304 | 2,556 | 210 | 78 | 84 | 1.167927 | 0.805154 | 0.974192 | 1.019441 | 1.164798 | 1.318903 | 1.367109 | 1.536957 | Netherlands | 0.578313 | 0.337349 | 0.512195 | 0.426829 | 0.45122 | 0.506173 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
false | null | REC | Boras | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999613422/101181982 | 2024-10-09 16:54:07 | SE | 470,501.75 | false | 57.7165456,12.8923395 | RISE RESEARCH INSTITUTES OF SWEDEN AB | 470,501.75 | SE232 | 2 | 999,613,422 | http://www.ri.se | 501 15 | PLANTOMYC | 101,181,982 | 1,905,804 | participant | RISE | BRINELLGATAN 4 | 470,501.75 | SE556464687401 | SWE | 2,021 | ALB | 0.349485 | 0.541802 | 320 | 4,745 | 380 | 78 | 87 | 1.224445 | 0.867613 | 1.028701 | 1.068138 | 1.222568 | 1.37962 | 1.42632 | 1.669371 | Sweden | 0.581395 | 0.360465 | 0.5 | 0.411765 | 0.411765 | 0.5 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
false | null | HES | Pamplona | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999641746/101181982 | 2024-10-09 16:54:07 | ES | 460,162.5 | false | 42.8185502,-1.6444164 | UNIVERSIDAD DE NAVARRA | 460,162.5 | ES220 | 10 | 999,641,746 | http://www.unav.es | 31080 | PLANTOMYC | 101,181,982 | 1,912,206 | participant | UNIVERSITY OF NAVARRA | CAMPUS UNIVERSITARIO EDIFICIO CENTRAL | 460,162.5 | ESR3168001J | ESP | 2,021 | ALB | 0.328814 | -0.339501 | 316 | 2,942 | 230 | 78 | 87 | 1.129384 | 0.678131 | 0.949979 | 0.98888 | 1.130769 | 1.272382 | 1.314985 | 1.541375 | Spain | 0.604651 | 0.395349 | 0.52381 | 0.423529 | 0.423529 | 0.511905 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
true | null | PRC | SCHAFFHAUSEN | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/963342406/101181982 | 2024-10-09 16:54:07 | CH | null | false | 47.6978259,8.6341027 | ESU-SERVICES GMBH | 0 | CH052 | 11 | 963,342,406 | http://www.esu-services.ch | 8200 | PLANTOMYC | 101,181,982 | 1,953,412 | associatedPartner | ESU | VORSTADT 10 | 0 | null | CHE | 2,021 | ALB | 0.347465 | 0.456836 | 304 | 2,874 | 225 | 78 | 87 | 0.731399 | 0.460281 | 0.593284 | 0.625079 | 0.730633 | 0.835157 | 0.859114 | 1.035163 | Switzerland | 0.453488 | 0.325581 | 0.583333 | 0.458824 | 0.458824 | 0.404762 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
true | null | PRC | Brndby | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/885309301/101181982 | 2024-10-09 16:54:07 | DK | 300,000 | false | 55.660274,12.421109 | BRØL ApS | 300,000 | DK012 | 5 | 885,309,301 | null | 2605 | PLANTOMYC | 101,181,982 | 1,989,943 | participant | BRØL ApS | Priorparken 530 | 300,000 | DK40193677 | DNK | 2,021 | ALB | 0.358399 | 0.914269 | 292 | 4,899 | 390 | 78 | 87 | 1.272888 | 0.830788 | 1.069651 | 1.116002 | 1.273871 | 1.433244 | 1.474729 | 1.654873 | Denmark | 0.604651 | 0.360465 | 0.488095 | 0.388235 | 0.435294 | 0.511905 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
false | null | PRC | Stockholm | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/935977639/101181982 | 2024-10-09 16:54:07 | SE | null | false | 59.3251172,18.0710935 | LANTMANNEN EKONOMISK FORENING | 0 | SE110 | 12 | 935,977,639 | null | 10425 | PLANTOMYC | 101,181,982 | 2,382,900 | associatedPartner | Lantmännen | not applicable | 0 | SE769605285601 | SWE | 2,021 | ALB | 0.349485 | 0.541802 | 320 | 4,745 | 380 | 78 | 87 | 1.224445 | 0.867613 | 1.028701 | 1.068138 | 1.222568 | 1.37962 | 1.42632 | 1.669371 | Sweden | 0.581395 | 0.360465 | 0.5 | 0.411765 | 0.411765 | 0.5 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
true | null | PRC | Madrid | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/905520609/101181982 | 2024-10-09 16:54:07 | ES | 341,000 | false | 40.4167047,-3.7035825 | EIT FOOD CLC SOUTH S.L. | 341,000 | ES300 | 9 | 905,520,609 | null | 28049 | PLANTOMYC | 101,181,982 | 1,957,178 | participant | null | C/ EINSTEIN 3 - CUIDAD UNIVERSTARIA DE CANTOBLANCO | 341,000 | ESB87964060 | ESP | 2,021 | ALB | 0.328814 | -0.339501 | 316 | 2,942 | 230 | 78 | 87 | 1.129384 | 0.678131 | 0.949979 | 0.98888 | 1.130769 | 1.272382 | 1.314985 | 1.541375 | Spain | 0.604651 | 0.395349 | 0.52381 | 0.423529 | 0.423529 | 0.511905 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
true | null | REC | Ornskoldsvik | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/993754040/101181982 | 2024-10-09 16:54:07 | SE | 1,133,502.5 | false | 63.2722345,18.6927813 | RISE PROCESSUM AB | 1,133,502.5 | SE321 | 1 | 993,754,040 | https://www.processum.se | 891 22 | PLANTOMYC | 101,181,982 | 1,932,623 | coordinator | PROCESSUM | HORNEBORGSVAGEN 12 | 1,133,502.5 | SE556641735701 | SWE | 2,021 | ALB | 0.349485 | 0.541802 | 320 | 4,745 | 380 | 78 | 87 | 1.224445 | 0.867613 | 1.028701 | 1.068138 | 1.222568 | 1.37962 | 1.42632 | 1.669371 | Sweden | 0.581395 | 0.360465 | 0.5 | 0.411765 | 0.411765 | 0.5 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
true | null | PRC | VASTRA FROLUNDA | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/890322843/101181982 | 2024-10-09 16:54:07 | SE | 642,950 | false | 57.6658779,11.9452385 | MILLOW AB | 642,950 | SE232 | 6 | 890,322,843 | null | 421 30 | PLANTOMYC | 101,181,982 | 1,988,312 | participant | null | GRUVGATAN 39B | 642,950 | SE559264953601 | SWE | 2,021 | ALB | 0.349485 | 0.541802 | 320 | 4,745 | 380 | 78 | 87 | 1.224445 | 0.867613 | 1.028701 | 1.068138 | 1.222568 | 1.37962 | 1.42632 | 1.669371 | Sweden | 0.581395 | 0.360465 | 0.5 | 0.411765 | 0.411765 | 0.5 | PLANTOMYC | 2024-10-09 16:54:07 | 4,618,367.5 | 2024-09-30 | 2028-12-31 | HORIZON | HORIZON-RIA | 10.3030/101181982 | 101,181,982 | HORIZON.2.6 | HORIZON-CL6-2024-FARM2FORK-01 | null | PLANTOMYC is a transformative initiative aiming to reshape the landscape of the alternative protein sector. It aims to bridge the versatile benefits of plant-based proteins with the functional and organoleptic (taste, aroma, texture) advantages of mycelial protein biomass (MPB) and develop innovative minimally processe... | 266,491 | 2025-01-01 | SIGNED | HORIZON-CL6-2024-FARM2FORK-01 | Production of superior meat analogues by bridging the benefits of plant proteins and mycelium protein biomass produced from circular substrates | HORIZON-CL6-2024-FARM2FORK-01-2 | 4,618,367.5 | W | Education & Training | Qualitative, Archival & Humanities Research Methods |
true | null | PRC | Zagreb | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/919962357/101168325 | 2024-08-02 14:38:36 | HR | 120,000 | false | 45.792501200000004,15.9089043 | NOTITIA DOO ZA SAVJETOVANJE I USLUGE | 120,000 | HR050 | 13 | 919,962,357 | null | 10000 | CarMen | 101,168,325 | 1,988,914 | participant | Notitia | HORVACANSKA 174 | 0 | HR51769285992 | HRV | 2,021 | ALB | 0.311133 | -1.115991 | 308 | 3,734 | 344 | 78 | 87 | 1.335457 | 0.972757 | 1.133938 | 1.171641 | 1.335665 | 1.498001 | 1.549425 | 1.738221 | Croatia | 0.604651 | 0.348837 | 0.488095 | 0.4 | 0.411765 | 0.52381 | CarMen | 2024-08-02 14:38:36 | 2,998,347.88 | 2024-07-19 | 2027-08-31 | HORIZON | HORIZON-RIA | 10.3030/101168325 | 101,168,325 | HORIZON.2.3 | HORIZON-CL3-2023-BM-01 | null | Challenges related to “on the move” biometrics are 1/ lower quality live biometric data, and 2/ no time to read the ePassport. Also, fully automatic biometric border control solutions, even with a stop allowed, are currently deployed only for pedestrians in controlled environments. Carmen innovates biometric solutions ... | 264,960 | 2024-09-01 | SIGNED | HORIZON-CL3-2023-BM-01 | CarMen | HORIZON-CL3-2023-BM-01-03 | 0 | K | Information & Communication Technologies | Sensor, Monitoring & Measurement Technologies |
false | null | PRC | Meudon | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/890652158/101168325 | 2024-08-02 14:38:36 | FR | 355,380 | false | 48.8208381,2.2332588 | THALES DIS FRANCE SAS | 355,380 | FR105 | 5 | 890,652,158 | null | 92190 | CarMen | 101,168,325 | 1,973,562 | participant | THALES DIS | 6 RUE DE LA VERRERIE | 0 | FR48844687749 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | CarMen | 2024-08-02 14:38:36 | 2,998,347.88 | 2024-07-19 | 2027-08-31 | HORIZON | HORIZON-RIA | 10.3030/101168325 | 101,168,325 | HORIZON.2.3 | HORIZON-CL3-2023-BM-01 | null | Challenges related to “on the move” biometrics are 1/ lower quality live biometric data, and 2/ no time to read the ePassport. Also, fully automatic biometric border control solutions, even with a stop allowed, are currently deployed only for pedestrians in controlled environments. Carmen innovates biometric solutions ... | 264,960 | 2024-09-01 | SIGNED | HORIZON-CL3-2023-BM-01 | CarMen | HORIZON-CL3-2023-BM-01-03 | 0 | K | Information & Communication Technologies | Sensor, Monitoring & Measurement Technologies |
false | null | PRC | Courbevoie | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/999766294/101168325 | 2024-08-02 14:38:36 | FR | 47,565 | false | 48.8239202,2.2678774 | IDEMIA IDENTITY & SECURITY FRANCE | 47,565 | FR105 | 6 | 999,766,294 | http://www.morpho.com | 92400 | CarMen | 101,168,325 | 1,905,630 | participant | IDEMIA ISF | 2, PLACE SAMUEL DE CHAMPLAIN | 0 | FR25440305282 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | CarMen | 2024-08-02 14:38:36 | 2,998,347.88 | 2024-07-19 | 2027-08-31 | HORIZON | HORIZON-RIA | 10.3030/101168325 | 101,168,325 | HORIZON.2.3 | HORIZON-CL3-2023-BM-01 | null | Challenges related to “on the move” biometrics are 1/ lower quality live biometric data, and 2/ no time to read the ePassport. Also, fully automatic biometric border control solutions, even with a stop allowed, are currently deployed only for pedestrians in controlled environments. Carmen innovates biometric solutions ... | 264,960 | 2024-09-01 | SIGNED | HORIZON-CL3-2023-BM-01 | CarMen | HORIZON-CL3-2023-BM-01-03 | 0 | K | Information & Communication Technologies | Sensor, Monitoring & Measurement Technologies |
false | null | HES | BREST | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/949423391/101168325 | 2024-08-02 14:38:36 | FR | 199,212.5 | false | 48.406848,-4.4953956 | YNCREA OUEST | 199,212.5 | FRH02 | 2 | 949,423,391 | null | 29200 | CarMen | 101,168,325 | 1,988,910 | participant | null | 20 RUE CUIRASSE BRETAGNE | 0 | null | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | CarMen | 2024-08-02 14:38:36 | 2,998,347.88 | 2024-07-19 | 2027-08-31 | HORIZON | HORIZON-RIA | 10.3030/101168325 | 101,168,325 | HORIZON.2.3 | HORIZON-CL3-2023-BM-01 | null | Challenges related to “on the move” biometrics are 1/ lower quality live biometric data, and 2/ no time to read the ePassport. Also, fully automatic biometric border control solutions, even with a stop allowed, are currently deployed only for pedestrians in controlled environments. Carmen innovates biometric solutions ... | 264,960 | 2024-09-01 | SIGNED | HORIZON-CL3-2023-BM-01 | CarMen | HORIZON-CL3-2023-BM-01-03 | 0 | K | Information & Communication Technologies | Sensor, Monitoring & Measurement Technologies |
true | null | PRC | AIX-EN-PROVENCE | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/contact-form/project/880204967/101168325 | 2024-08-02 14:38:36 | FR | 200,484.3 | false | 43.570984749999994,5.382418908847484 | ARCLAN'SYSTEM | 200,484.3 | FRL04 | 8 | 880,204,967 | null | 13795 | CarMen | 101,168,325 | 1,988,912 | participant | null | ACTIMART II LOTISSEMENT 9 1140 RUE AMPERE | 0 | FR03342801974 | FRA | 2,021 | ALB | 0.338 | 0.055395 | 301 | 2,787 | 220 | 78 | 87 | 1.578638 | 1.175008 | 1.368643 | 1.416094 | 1.577935 | 1.739512 | 1.78153 | 1.992883 | France | 0.627907 | 0.383721 | 0.476191 | 0.364706 | 0.411765 | 0.571429 | CarMen | 2024-08-02 14:38:36 | 2,998,347.88 | 2024-07-19 | 2027-08-31 | HORIZON | HORIZON-RIA | 10.3030/101168325 | 101,168,325 | HORIZON.2.3 | HORIZON-CL3-2023-BM-01 | null | Challenges related to “on the move” biometrics are 1/ lower quality live biometric data, and 2/ no time to read the ePassport. Also, fully automatic biometric border control solutions, even with a stop allowed, are currently deployed only for pedestrians in controlled environments. Carmen innovates biometric solutions ... | 264,960 | 2024-09-01 | SIGNED | HORIZON-CL3-2023-BM-01 | CarMen | HORIZON-CL3-2023-BM-01-03 | 0 | K | Information & Communication Technologies | Sensor, Monitoring & Measurement Technologies |
End of preview. Expand in Data Studio
No dataset card yet
- Downloads last month
- 2